Allurion Technologies (NYSE:ALUR – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Tuesday, May 14th. Allurion Technologies has set its FY 2024 guidance at EPS.Individual interested in participating in the company’s earnings conference call can do so using this link.
Allurion Technologies (NYSE:ALUR – Get Free Report) last released its quarterly earnings data on Thursday, March 21st. The company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.51) by ($0.12). The company had revenue of $8.24 million for the quarter, compared to analysts’ expectations of $8.20 million. On average, analysts expect Allurion Technologies to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Allurion Technologies Stock Performance
Shares of NYSE ALUR opened at $2.14 on Tuesday. Allurion Technologies has a 1 year low of $1.56 and a 1 year high of $9.00. The company has a 50 day simple moving average of $2.31 and a 200-day simple moving average of $3.12.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on Allurion Technologies
About Allurion Technologies
Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
Recommended Stories
- Five stocks we like better than Allurion Technologies
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Hims & Hers Health Stock Could Become a Wealth Compounder
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 Penny Stocks That Insiders Are Buying
- How Can Investors Benefit From After-Hours Trading
- Traders Sell but Investors Still Win After Palantir’s Earnings
Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.